Democratizing Glaucoma Care: A Framework for AI-Driven Progression Prediction Across Diverse Healthcare Settings.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Epidemiological Trends and Inequalities in Eye Injuries Among Children and Adolescents Aged 0-19 Years: A Comprehensive Analysis of Global, Regional, and National Data From 1990 to 2021.Journal of ophthalmology · 2026
   Article
2. Augmented Decisions: AI-Enhanced Accuracy in Glaucoma Diagnosis and Treatment.Journal of clinical medicine · 2025
   Review
3. Artificial Intelligence in Glaucoma: Advances in Diagnosis, Progression Forecasting, and Surgical Outcome Prediction.International journal of molecular sciences · 2025
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as